Clinical trialNCT07042581RecruitingPhase 4Interventional

A Study of Revaree Plus in People With Breast Cancer

SponsorMemorial Sloan Kettering Cancer CenterEnrollment60Breast CancerHormone Receptor Positive Breast CarcinomaHormone Receptor Positive Malignant Neoplasm of BreastHormone-receptor-positive Breast CancerStage 0 Breast CancerStage 0 Breast Carcinoma+5 more conditions

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness during breast cancer treatment.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Shari Goldfarb, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Memorial Sloan Kettering Basking Ridge (consent Only)
Basking Ridge, New Jersey, United States
Recruiting
Memorial Sloan Kettering Monmouth (consent Only)
Middletown, New Jersey, United States
Recruiting
Memorial Sloan Kettering Bergen (consent Only)
Montvale, New Jersey, United States
Recruiting
Memorial Sloan Kettering Cancer Center Suffolk-Commack (consent Only)
Commack, New York, United States
Recruiting
Memorial Sloan Kettering Westchester (consent Only)
Harrison, New York, United States
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting
Memorial Sloan Kettering Nassau (consent Only)
Uniondale, New York, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Revaree Plus

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 Jun 2025
Primary completion: 20 Jun 2029
Completion: 20 Jun 2029
Last update posted: 6 Feb 2026
Registered enrollment: 60
Registry id: NCT07042581

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.